/
ATYR
$0.55+$0.01 (+2.35%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$53.0M
98M shares
52-week range
$0.40 – $6.50
3% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
CS
Change$-1.27
aTyr Pharma, Inc. Common Stock
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
www.atyrpharma.com- Employees
- 58
- IPO / List date
- May 7, 2015
- HQ
- SAN DIEGO, CA
Held by traders on TradeandTell
No one on the platform currently holds ATYR.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 40,522 | $31.6K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ATYR yet.
